ZAP70 IN T CELL DEVELOPMENT
ZAP70 IN T CELL DEVELOPMENT
批准号:
2871966
负责人:
ANDREW C CHAN
金额:
$17.81万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1998
资助国家:
美国
项目状态:
已结题
起止时间:
1998-04-17 至 2003-01-31
中文摘要
性状(改编自研究者摘要):蛋白酪氨酸
蛋白激酶(PTK)在T细胞的发育中起着不可或缺的作用。
许多细胞质PTK的突变或缺失导致多种细胞质PTK的产生。
免疫缺陷 一种这样的PTK是ζ-链相关的PTK,ZAP-70。
在人类和小鼠中的研究证明了ZAP-70的核心重要性
在T细胞发育和T细胞发育功能中。 不存在人
ZAP-70与一种常染色体隐性形式的严重联合
免疫缺陷。 这些患者不产生CD 8+外周T细胞,
无功能性CD 4 + T细胞数量正常。 缺乏ZAP-70的小鼠
基因缺乏CD 4+和CD 8+外周T细胞。 此外,ZAP-70也是
需要适当的选择和发展的T细胞。 而
这些初步研究表明,ZAP-70在
胸腺细胞发育和TCR库的适当选择,
ZAP-70可以介导这些广泛多样的生物学机制
答复仍不清楚。 了解ZAP-70如何在
胸腺细胞发育将为免疫细胞中PTKs提供范例
发展,并可能提供对发展差异的见解,
需要CD 4+和CD 8 + T细胞。 此外,这些研究可能提供
药物治疗干预的额外机制信息
设计用于T细胞淋巴瘤、免疫缺陷、自身免疫性疾病和
移植排斥反应
英文摘要
DESCRIPTION (Adapted from Investigator's abstract): Protein tyrosine
kinases (PTKs) play an integral role in the development of T cells.
Mutations or the absence of a number of cytoplasmic PTKs result a variety of
immunodeficiencies. One such PTK is the zeta-chain associated PTK, ZAP-70.
Studies in both humans and mice demonstrate the central importance of ZAP-70
in T cell development and T cell development function. Absence of human
ZAP-70 is associated with an autosomal recessive form of severe combined
immunodeficiency. These patients develop no CD8+ peripheral T cells and
have normal numbers of nonfunctional CD4+ T cells. Mice lacking the ZAP-70
gene lack both CD4+ and CD8+ peripheral T cells. Moreover, zap-70 is also
required for the appropriate selection and development of T cells. While
these initial studies demonstrate the central importance of ZAP-70 in
thymocyte development and appropriate selection of the TCR repertoire, the
mechanism(s) by which ZAP-70 can mediate these vastly diverse biological
responses remain unclear. An understanding of how ZAP-70 functions in
thymocyte development will provide a paradigm for PTKs in immune cell
development and may provide insights into differences in the developmental
requirements of CD4+ and CD8+ T cells. Moreover, these studies may provide
additional mechanistic information for therapeutic interventions in drug
design for T cell lymphomas, immunodeficiencies, autoimmune diseases, and
transplantation rejection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Syk in lymphocyte activation
-
批准号:6652713
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2002
-
负责人:ANDREW C CHAN
-
依托单位:
Syk in lymphocyte activation
-
批准号:6492292
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2001
-
负责人:ANDREW C CHAN
-
依托单位:
ROLE OF SYK PROTEIN TYROSINE KINASE IN IMMUNE FUNCTION
-
批准号:6374476
-
项目类别:
-
资助金额:$72.36万
-
财政年份:2000
-
负责人:ANDREW C CHAN
-
依托单位:
ROLE OF SYK PROTEIN TYROSINE KINASE IN IMMUNE FUNCTION
-
批准号:6090781
-
项目类别:
-
资助金额:$72.42万
-
财政年份:2000
-
负责人:ANDREW C CHAN
-
依托单位:
Syk in lymphocyte activation
-
批准号:6400344
-
项目类别:
-
资助金额:$24.14万
-
财政年份:2000
-
负责人:ANDREW C CHAN
-
依托单位:
BLNK PROTEINS IN B CELL RECEPTOR FUNCTION
-
批准号:2590946
-
项目类别:
-
资助金额:$16.91万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
ZAP70 IN T CELL DEVELOPMENT
-
批准号:2610215
-
项目类别:
-
资助金额:$17.03万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
ZAP70 IN T CELL DEVELOPMENT
-
批准号:6150316
-
项目类别:
-
资助金额:$18.62万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
BLNK PROTEINS IN B CELL RECEPTOR FUNCTION
-
批准号:6149879
-
项目类别:
-
资助金额:$18.99万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
ZAP70 IN T CELL DEVELOPMENT
-
批准号:6350237
-
项目类别:
-
资助金额:$19.47万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
BLNK PROTEINS IN B CELL RECEPTOR FUNCTION
-
批准号:2871574
-
项目类别:
-
资助金额:$17.94万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
BLNK PROTEINS IN B CELL RECEPTOR FUNCTION
-
批准号:6349851
-
项目类别:
-
资助金额:$19.56万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
BLNK PROTEINS IN B CELL RECEPTOR FUNCTION
-
批准号:6497096
-
项目类别:
-
资助金额:$20.15万
-
财政年份:1998
-
负责人:ANDREW C CHAN
-
依托单位:
ACTIVATION MECHANISMS OF THE SKY PROTEIN TYROSINE KINASE
-
批准号:2443274
-
项目类别:
-
资助金额:$12.21万
-
财政年份:1996
-
负责人:ANDREW C CHAN
-
依托单位:
ACTIVATION MECHANISMS OF THE SKY PROTEIN TYROSINE KINASE
-
批准号:2115116
-
项目类别:
-
资助金额:$11.89万
-
财政年份:1996
-
负责人:ANDREW C CHAN
-
依托单位:
ACTIVATION MECHANISMS OF THE SKY PROTEIN TYROSINE KINASE
-
批准号:2733249
-
项目类别:
-
资助金额:$12.7万
-
财政年份:1996
-
负责人:ANDREW C CHAN
-
依托单位:
ZAP-70, A T CELL RECEPTOR ZETA CHAIN ASSOCIATED PROTEIN
-
批准号:3747747
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:ANDREW C CHAN
-
依托单位:
海外基金